Aktis Oncology, INC

Ken Herrmann, a Director of Aktis Oncology, Inc., sold 4,856 shares of common stock on July 20, 2026 for $24.56 per share.

Ken Herrmann, a Director of Aktis Oncology, Inc., sold 3,065 shares of common stock on July 17, 2026 for $25.21 per share.

Aktis Oncology, Inc. Chief Operating Officer Shulamit Ron-Bigger reported transactions involving the acquisition and sale of company stock.

Aktis Oncology's Chief Medical Officer, Akos Czibere, reported transactions involving the sale of company stock and the exercise of stock options.